705 related articles for article (PubMed ID: 26159728)
41. Metacognitive deficits predict future levels of negative symptoms in schizophrenia controlling for neurocognition, affect recognition, and self-expectation of goal attainment.
Lysaker PH; Kukla M; Dubreucq J; Gumley A; McLeod H; Vohs JL; Buck KD; Minor KS; Luther L; Leonhardt BL; Belanger EA; Popolo R; Dimaggio G
Schizophr Res; 2015 Oct; 168(1-2):267-72. PubMed ID: 26164820
[TBL] [Abstract][Full Text] [Related]
42. Cognitive functioning in first-episode schizophrenia: MATRICS Consensus Cognitive Battery (MCCB) Profile of Impairment.
McCleery A; Ventura J; Kern RS; Subotnik KL; Gretchen-Doorly D; Green MF; Hellemann GS; Nuechterlein KH
Schizophr Res; 2014 Aug; 157(1-3):33-9. PubMed ID: 24888526
[TBL] [Abstract][Full Text] [Related]
43. The relative influences of symptoms, insight, and neurocognition on social adjustment in schizophrenia and schizoaffective disorder.
Smith TE; Hull JW; Goodman M; Hedayat-Harris A; Willson DF; Israel LM; Munich RL
J Nerv Ment Dis; 1999 Feb; 187(2):102-8. PubMed ID: 10067950
[TBL] [Abstract][Full Text] [Related]
44. Cognitive and clinical predictors of community functioning across the psychoses.
Lewandowski KE; Cohen TR; Ongur D
Psych J; 2020 Apr; 9(2):163-173. PubMed ID: 32208557
[TBL] [Abstract][Full Text] [Related]
45. The relationship of cognitive improvement after cognitive remediation with social functioning in patients with schizophrenia and severe cognitive deficits.
Lindenmayer JP; Fregenti S; Kang G; Ozog V; Ljuri I; Khan A; Goldring A; McGurk SR
Schizophr Res; 2017 Jul; 185():154-160. PubMed ID: 28094171
[TBL] [Abstract][Full Text] [Related]
46. Neurocognition and social cognition in patients with schizophrenia spectrum disorders with and without a history of violence: results of a multinational European study.
Iozzino L; Harvey PD; Canessa N; Gosek P; Heitzman J; Macis A; Picchioni M; Salize HJ; Wancata J; Koch M; Ferrari C; de Girolamo G
Transl Psychiatry; 2021 Dec; 11(1):620. PubMed ID: 34880208
[TBL] [Abstract][Full Text] [Related]
47. Differences in Neuropsychological Functioning Between Homicidal and Nonviolent Schizophrenia Samples.
Stratton J; Cobia DJ; Reilly J; Brook M; Hanlon RE
J Forensic Sci; 2018 Sep; 63(5):1435-1443. PubMed ID: 29411382
[TBL] [Abstract][Full Text] [Related]
48. Neurocognition in early-onset schizophrenia and schizoaffective disorders.
Hooper SR; Giuliano AJ; Youngstrom EA; Breiger D; Sikich L; Frazier JA; Findling RL; McClellan J; Hamer RM; Vitiello B; Lieberman JA
J Am Acad Child Adolesc Psychiatry; 2010 Jan; 49(1):52-60. PubMed ID: 20215926
[TBL] [Abstract][Full Text] [Related]
49. The prospective relationships among intrinsic motivation, neurocognition, and psychosocial functioning in schizophrenia.
Nakagami E; Hoe M; Brekke JS
Schizophr Bull; 2010 Sep; 36(5):935-48. PubMed ID: 20462998
[TBL] [Abstract][Full Text] [Related]
50. Neurocognition and occupational functioning in schizophrenia spectrum disorders: The MATRICS Consensus Cognitive Battery (MCCB) and workplace assessments.
Lystad JU; Falkum E; Haaland VØ; Bull H; Evensen S; Bell MD; Ueland T
Schizophr Res; 2016 Jan; 170(1):143-9. PubMed ID: 26692347
[TBL] [Abstract][Full Text] [Related]
51. A new computerized cognitive and social cognition training specifically designed for patients with schizophrenia/schizoaffective disorder in early stages of illness: A pilot study.
Fernandez-Gonzalo S; Turon M; Jodar M; Pousa E; Hernandez Rambla C; García R; Palao D
Psychiatry Res; 2015 Aug; 228(3):501-9. PubMed ID: 26163731
[TBL] [Abstract][Full Text] [Related]
52. A neuropsychological investigation into violence and mental illness.
Barkataki I; Kumari V; Das M; Hill M; Morris R; O'Connell P; Taylor P; Sharma T
Schizophr Res; 2005 Apr; 74(1):1-13. PubMed ID: 15694749
[TBL] [Abstract][Full Text] [Related]
53. Preserved cognitive function is associated with suicidal ideation and single suicide attempts in schizophrenia.
Delaney C; McGrane J; Cummings E; Morris DW; Tropea D; Gill M; Corvin A; Donohoe G
Schizophr Res; 2012 Sep; 140(1-3):232-6. PubMed ID: 22796150
[TBL] [Abstract][Full Text] [Related]
54. Neurocognition and Duration of Psychosis: A 10-year Follow-up of First-Episode Patients.
Rund BR; Barder HE; Evensen J; Haahr U; ten Velden Hegelstad W; Joa I; Johannessen JO; Langeveld J; Larsen TK; Melle I; Opjordsmoen S; Røssberg JI; Simonsen E; Sundet K; Vaglum P; McGlashan T; Friis S
Schizophr Bull; 2016 Jan; 42(1):87-95. PubMed ID: 26101305
[TBL] [Abstract][Full Text] [Related]
55. Neurocognitive predictors of remission of symptoms and social and role functioning in the early course of first-episode schizophrenia.
Torgalsbøen AK; Mohn C; Rishovd Rund B
Psychiatry Res; 2014 Apr; 216(1):1-5. PubMed ID: 24530159
[TBL] [Abstract][Full Text] [Related]
56. Psychopathy and violent behavior among patients with schizophrenia or schizoaffective disorder.
Nolan KA; Volavka J; Mohr P; Czobor P
Psychiatr Serv; 1999 Jun; 50(6):787-92. PubMed ID: 10375148
[TBL] [Abstract][Full Text] [Related]
57. Motivation and its relationship to neurocognition, social cognition, and functional outcome in schizophrenia.
Gard DE; Fisher M; Garrett C; Genevsky A; Vinogradov S
Schizophr Res; 2009 Nov; 115(1):74-81. PubMed ID: 19783407
[TBL] [Abstract][Full Text] [Related]
58. Towards an integrative approach to understanding quality of life in schizophrenia: the role of neurocognition, social cognition, and psychopathology.
Tas C; Brown E; Cubukcuoglu Z; Aydemir O; Danaci AE; Brüne M
Compr Psychiatry; 2013 Apr; 54(3):262-8. PubMed ID: 22998842
[TBL] [Abstract][Full Text] [Related]
59. Social cognition as a mediator between neurocognition and functional outcome in individuals at clinical high risk for psychosis.
Barbato M; Liu L; Penn DL; Keefe RS; Perkins DO; Woods SW; Addington J
Schizophr Res; 2013 Nov; 150(2-3):542-6. PubMed ID: 24012459
[TBL] [Abstract][Full Text] [Related]
60. Symptoms versus neurocognition as predictors of change in life skills in schizophrenia after outpatient rehabilitation.
Kurtz MM; Wexler BE; Fujimoto M; Shagan DS; Seltzer JC
Schizophr Res; 2008 Jul; 102(1-3):303-11. PubMed ID: 18495433
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
